# Raykol Group (Xiamen) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/raykol-group-xiamen-co

- Industry: Industrial Machinery
- Headquarters: Xiamen, China
- Website: www.raykol.com
- Total disclosed funding: $15M
- Latest round: Series A (Jun 14, 2022)
- Investors on record: 2

## About

Established in 2010 and based in Xiamen, China, Raykol Group (Xiamen) Co., Ltd. is a provider of automated and intelligent laboratory solutions focused on improving the performance of the inspection and testing industry. The company started from chemical analysis automation pre-processing technology, and has 6 subsidiaries, 1 research institute and 3 research and development bases, with more than 500 full-time employees. In early 2022, the company integrated Shanghai Xintuo through merger and acquisition.

The company's core business covers three fields: food safety, environmental protection, life sciences, providing a variety of self-developed products, including physical and chemical laboratory automation equipment, including Fotector Plus high-throughput automatic solid phase extractor, etc.; life science automation equipment, including Vitae 60 automatic pipetting workstation, etc.; and analytical instruments and reagent consumables. 2019 the company launched multifunctional The ISP series of sample preparation workstations combines up to 30 modules for sample management, liquid handling, lid opening and closing, shaking extraction, centrifugation, etc., making it possible to achieve unmanned sample preparation process. The company's products are widely used in pharmaceutical testing, life science, medical and health fields.

The company raised a series A funding in June 2022, This round of funding will be used to increase research and development investment, expand multiple product lines such as life science automation pre-processing equipment, multi-functional preparation workstations and reagent consumables, and strengthen product development and technology upgrade in the field of life science automation.

## Funding rounds

- Series A, Jun 14, 2022, $15M — Riverhead Capital, Sherpa Healthcare Partners

## Investors

- Riverhead Capital (https://capitalatlas.ai/funds/riverhead-capital) — Series A
- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Series A